The Future of Gene Therapy

by Bidita Debnath on  July 22, 2014 at 10:39 PM Research News   - G J E 4
In cortical neurons, hypoxia-inducible factor 1 (HIF-1) attenuates amyloid-beta protein neurotoxicity and decreases apoptosis induced by oxidative stress or hypoxia.
 The Future of Gene Therapy
The Future of Gene Therapy

Prof. Xiqing Chai and co-workers from Hebei Chemical and Pharmaceutical College, China constructed a recombinant adeno-associated virus (rAAV) vector expressing the human HIF-1α gene (rAAV-HIF-1α) efficiently, and tested the assumption that rAAV-HIF-1α represses hippocampal neuronal apoptosis induced by amyloid-beta protein.

Their results confirmed that rAAV-HIF-1α significantly reduces apoptosis induced by amyloid-beta protein in primary cultured hippocampal neurons. This mechanism may be related to HIF-1α-decreased hippocampal neuronal intracellular calcium concentration ([Ca2+]i), thereby inhibiting apoptotic cascade reactions.

With these investigations published in the Neural Regeneration Research (Vol. 9, No. 11, 2014), gene therapy using rAAV to deliver HIF-1α may ultimately provide a new option for clinical treatment of Alzheimer's disease.

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like